JACI-Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19) A multicenter, single-blind, randomized controlled trial

JACI-Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19) A multicenter, single-blind, randomized controlled trial

75JACI~1

Download

Online consultation

Before downloading the file, please fill in the following form information

Submit
Baidu
betway必威